Research Paper Volume 16, Issue 8 pp 6954—6989
Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification
Figure 9. Prediction of LAPTM4A expression-related drugs. (A) An advanced network diagram shows 37 cancer-related drugs that can modulate LAPTM4A expression. (B) A Venn diagram demonstrates drugs related to LAPTM4A expression in CTD and cgp2016. (C) Relationship between LAPTM4A expression and IC50 of doxorubicin. (D) LAPTM4A is resistant to 73 drugs and sensitive to 9 drugs.